<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Molekulyarnaya Meditsina (Molecular medicine)</journal-id><journal-title-group><journal-title xml:lang="en">Molekulyarnaya Meditsina (Molecular medicine)</journal-title><trans-title-group xml:lang="ru"><trans-title>Молекулярная медицина</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1728-2918</issn><issn publication-format="electronic">2499-9490</issn><publisher><publisher-name xml:lang="en">Russkiy Vrach Publishing House</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">113438</article-id><article-id pub-id-type="doi">10.29296/24999490-2021-04-02</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">The role of VEGF and microRNA in the formation of the endometrioid phenotype of endometrial cells</article-title><trans-title-group xml:lang="ru"><trans-title>Роль VEGF и микроРНК в формировании эндометриоидного фенотипа клеток эндометрия</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Ukrainets</surname><given-names>Roman Vadimovich</given-names></name><name xml:lang="ru"><surname>Украинец</surname><given-names>Роман Вадимович</given-names></name></name-alternatives><bio xml:lang="en"><p>pathologists in the Department of Clinical Pathology №2</p></bio><bio xml:lang="ru"><p>врач-патологоанатом отделения клинической патологии №2; Ассистент кафедры патологической анатомии</p></bio><email>ukrainets.roman@yandex.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Korneva</surname><given-names>Yulia Sergeevna</given-names></name><name xml:lang="ru"><surname>Корнева</surname><given-names>Юлия Сергеевна</given-names></name></name-alternatives><bio xml:lang="en"><p>Sergeevna - PhD, Associate Professor of the Department of Pathological Anatomy</p></bio><bio xml:lang="ru"><p>кандидат медицинских наук, доцент кафедры патологической анатомии; врач-патологоанатом отделения клинической патологии №2</p></bio><email>ksu1546@yandex.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Smolensk State Medical University</institution></aff><aff><institution xml:lang="ru">ФГБОУВО «Смоленский государственный медицинский университет» Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Smolensk Regional Institute of Pathology</institution></aff><aff><institution xml:lang="ru">ОГБУЗ «Смоленский областной институт патологии»</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2021-04-15" publication-format="electronic"><day>15</day><month>04</month><year>2021</year></pub-date><volume>19</volume><issue>4</issue><issue-title xml:lang="en">VOL 19, NO4 (2021)</issue-title><issue-title xml:lang="ru">ТОМ 19, №4 (2021)</issue-title><fpage>10</fpage><lpage>14</lpage><history><date date-type="received" iso-8601-date="2022-11-18"><day>18</day><month>11</month><year>2022</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2021, Russkiy Vrach Publishing House</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2021, ИД "Русский врач"</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="en">Russkiy Vrach Publishing House</copyright-holder><copyright-holder xml:lang="ru">ИД "Русский врач"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2026-04-15"/></permissions><self-uri xlink:href="https://journals.eco-vector.com/1728-2918/article/view/113438">https://journals.eco-vector.com/1728-2918/article/view/113438</self-uri><abstract xml:lang="en"><p>This review attempts to generalize current data on the role of microRNAs in the pathogenesis of endometriosis and their pathogenetic relationship with the main pathomorphological phenomena in this pathology. Nowadays, many microRNAs were studied to clarify the pathogenesis of endometriosis and its reliable diagnostic marker. The difference between heterotopic endometrioid cells and intact endometrial cells is referred to in the literature as «endometrioid phenotype formation» and probably depends on changes in the expression of specific microRNAs. Increasing VEGF expression in endometriosis has a common pathogenetic axis with impaired expression of many microRNAs, like miR-29c, miR-33b, miR-199a-5p, and miR-210. Probably, changes in the expression of these microRNAs lead to the formation of an endometrioid phenotype. The subsequent pathogenetic cascade in the form of changes in the expression of miR-145 and miR-451 promotes the formation of endometriosis-associated infertility. Changes in the expression of miR-199a-5p, miR-125b-5P and miR-191 in turn increase the risk of malignization of endometrioid heterotopia. This data may serve to create both prevention and targeted therapy for endometriosis and related infertility, as well as to prevent the development of endometriosis-associated cancer.</p></abstract><trans-abstract xml:lang="ru"><p>Данный обзор является попыткой обобщения современных данных о роли микроРНК в патогенезе эндометриоза и их патогенетической связи с основными патоморфологическими проявлениями при данной патологии. На сегодняшний день исследуется большое количество микроРНК с целью уточнения патогенеза эндометриоза, а также его надежного диагностического маркера. Известно, что клетки эндометриоидной гетеротопии отличаются от клеток нормального эндометрия, что в литературе именуется как «формирование эндометриоидного фенотипа» и, вероятно, зависит от изменения экспрессии специфичных микроРНК. Возрастающая экспрессия VEGF при эндометриозе имеет общую патогенетическую ось с нарушением экспрессии ряда микроРНК, а именно - miR-29c, miR-33b, miR-199a-5p и miR-210. Вероятно, изменения экспрессии именно указанных микроРНК приводят к формированию эндометриоидного фенотипа, а последующий патогенетический каскад в виде изменения экспрессии miR- 145 и miR-451 участвует в формировании эндометриоз-ассоциированного бесплодия; в свою очередь, изменение экспрессии miR-199a-5p, miR-125b-5р и miR-191 повышает риск малигнизации эндометриоидной гетеротопии. Полученные данные могут послужить для разработки как профилактики, так и таргетной терапии эндометриоза и связанного с ним бесплодия, а также для предотвращения развития эндометриоз-ассоциированного рака.</p></trans-abstract><kwd-group xml:lang="en"><kwd>VEGF</kwd><kwd>endometriosis</kwd><kwd>microRNA</kwd><kwd>endometrioid phenotype</kwd><kwd>VEGF</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>эндометриоз</kwd><kwd>микроРНК</kwd><kwd>эндометриоидный фенотип</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Файзуллин Л.З., Карнаухов В.Н., Адамян Л.В., Горшкова О.Н., Хилькевич Е.Г., Чупрынин В.Д., Трофимов Д.Ю., Аракелян А.С. Влияние окружающей ткани на оценку экспрессии микроРНК в эктопическом эндометрии при тяжелом эндометриозе. Акушерство и гинекология. 2016; 9: 109-13.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Альмова И.К., Бобров М.Ю., Чупрынин B.Д., Хилькевич Е.Г., Чурсин В.В., Мельников М.В., Буралкина Н.А., Вередченко А.В. Диагностическая роль микроРНК как биологических маркеров наружного (ретроцервикального) эндометриоза. Акушерство и гинекология. 2017; 8: 34-40.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Chen K., Rajewsky N. The evolution of gene regulation by transcription factors and microRNAs. Nature Reviews Genetics. 2007, 8 (2): 93-103.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Capobianco A., Monno A., Cottone L., Venneri M.A., Biziato D., Di Puppo F., Ferrari S., De Palma M., Manfredi A.A., Rovere-Querini P. Proangiogenic Tie2(+) macrophages infiltrate human and murine endometriotic lesions and dictate their growth in a mouse model of the disease. Am J. Pathol. 2011; 179 (5): 2651-9. https://doi.org/10.1016/j.ajpath.2011.07.029</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Machado D.E., Rodrigues-Baptista K.C., Alessandra-Perini J., Soares de Moura R., Santos T.A., Pereira K.G., Marinho da Silva Y., Souza P.J., Nasciutti L.E., Perini J.A. Euterpe oleracea Extract (A?ai) Is a Promising Novel Pharmacological Therapeutic Treatment for Experimental Endometriosis. PLoS One. 2016; 11 (11): e0166059. https://doi.org/10.1371/journal.pone.0166059</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Okamoto M., Nasu K., Abe W., Aoyagi Y., Kawano Y., Kai K., Moriyama M., Narahara H. Enhanced miR-210 expression promotes the pathogenesis of endometriosis through activation of signal transducer and activator of transcription 3. Hum Reprod. 2015; 30 (3): 632-41. https://doi.org/10.1093/hum-rep/deu332</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Yang W.W., Hong L., Xu X.X., Wang Q., Huang J.L., Jiang L. Regulation of miR-33b on endometriosis and expression of related factors. Eur Rev Med Pharmacol Sci. 2017; 21 (9): 2027-33.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Braza-Boils A., Salloum-Asfar S., Mari-Alexandre J., Arroyo A.B., Gonzalez-Conejero R., Barcelo-Molina M., Garcia-Oms J., Vicente V., Estelles A., Gilabert-Estelles J., Martinez C. Peritoneal fluid modifies the microRNA expression profile in endometrial and endometriotic cells from women with endometriosis. Hum Reprod. 2015; 30 (10): 2292-302. https://doi.org/10.1093/humrep/dev204</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Hsu C.Y., Hsieh T.H., Tsai C.F., Tsai H.P., Chen H.S., Chang Y., Chuang H.Y., Lee J.N., Hsu Y.L., Tsai E.M. miRNA-199a-5p regulates VEGFA in endometrial mesenchymal stem cells and contributes to the pathogenesis of endometriosis. J. Pathol. 2014; 232 (3): 330-43. https://doi.org/10.1002/path.4295</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Yu H., Zhong Q., Xia Y., Li E., Wang S., Ren R. MicroRNA-2861 targets STAT3 and MMP2 to regulate the proliferation and apoptosis of ectopic endometrial cells in endometriosis. Pharmazie. 2019; 74 (4): 243-9. https://doi.org/10.1691/ph.2019.8881</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Abe W., Nasu K., Nakada C., Kawano Y., Moriyama M., Narahara H. miR-196b targets c-myc and Bcl-2 expression, inhibits proliferation and induces apoptosis in endometriotic stromal cells. Hum Reprod. 2013; 28(3): 750-61. https://doi.org/10.1093/humrep/des446</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Shi X.Y., Gu L., Chen J., Guo X.R., Shi Y.L. Downregulation of miR-183 inhibits apoptosis and enhances the invasive potential of endometrial stromal cells in endometriosis. Int J. Mol. Med. 2014; 33 (1): 59-67. https://doi.org/10.3892/ijmm.2013.1536</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>He S.Z., Li J., Bao H.C., Wang M.M., Wang X.R., Huang X., Li F.H., Zhang W., Xu A.L., Fang H.C., Sheng Y.X. G. protein coupled estrogen receptor/miR 148a/human leukocyte antigen G. signaling pathway mediates cell apoptosis of ovarian endometriosis. Mol Med Rep. 2018; 18 (1): 1141-8. https://doi.org/10.3892/mmr.2018.9039</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Liu S., Qiu J., Tang X., Cui H., Zhang Q., Yang Q. LncRNA-H19 regulates cell proliferation and invasion of ectopic endometrium by targeting ITGB3 via modulating miR-124-3p. Exp Cell Res. 2019; 381 (2): 215-22. https://doi.org/10.1016/j.yexcr.2019.05.010</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Hsu C.Y., Hsieh T.H., Er T.K., Chen H.S., Tsai C.C., Tsai E.M. MiR 381 regulates cell motility, growth and colony formation through PIK3CA in endometriosis associated clear cell and endometrioid ovarian cancer. Oncol Rep. 2018; 40 (6): 3734-42. https://doi.org/10.3892/or.2018.6779</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Du X.H., Shi G., Lu D.H., Wang Y.H., Chen J.T., Zheng Q., Yin X. The Expression of micro-RNA-221 in Endometriosis and Its Impact on Endometrial Stromal Cells. Sichuan Da Xue Xue Bao Yi Xue Ban. 2018; 49 (4): 546-50.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Adammek M., Greve B., Kassens N., Schneider C., Bruggemann K., Schuring A.N., Starzinski-Powitz A., Kiesel L., Gotte M. MicroRNA miR-145 inhibits proliferation, invasiveness, and stem cell phenotype of an in vitro endometriosis model by targeting multiple cytoskeletal elements and pluripotency factors. Fertil Steril. 2013; 99 (5): 1346-55.e5. https://doi.org/10.10Wj.fertnstert.2012.11.055</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Zhang H., Li G., Sheng X., Zhang S. Upregulation of miR-33b promotes endometriosis via inhibition of Wnt/p catenin signaling and ZEB1 expression. Mol Med Rep. 2019; 19 (3): 2144-52. https://doi.org/10.3892/mmr.2019.9870</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Zhang P., Sun Y., Ma L. ZEB1: at the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistance. Cell Cycle. 2015; 14 (4): 481-7. https://doi.org/10.1080/15384101.2015.1006048</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Senol S., Sayar I., Ceyran A.B., Ibiloglu I., Akalin I., Firat U. Stromal Clues in Endometrial Carcinoma: Loss of Expression of p-Catenin, Epithelial-Mesenchymal Transition Regulators, and Estrogen-Progester-one Receptor. Int J. Gynecol Pathol. 2016; 35 (3): 238-48. https://doi.org/10.1097/ PGP.0000000000000233</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Konrad L., Gronbach J., Horne F., Mecha E.O., Berkes E., Frank M. Similar Characteristics of Endometrial and Endometriotic Epithelial Cells. Reprod Sci. 2019; 26 (1): 49-59. https://doi.org/10.1177/1933719118756745</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Oh S.J., Shin J.H., Kim T.H., Lee H.S., Yoo J.Y., Ahn J.Y. p-Catenin activation contributes to the pathogenesis of adenomyosis through epithelial-mesenchymal transition. J. Pathol. 2013; 231 (2): 210-22. https://doi.org/10.1002/path.4224</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Liang Z., Chen Y., Zhao Y., Xu C., Zhang A., Zhang Q., Wang D., He J., Hua W., Duan P. miR-200c suppresses endometriosis by targeting MALAT1 in vitro and in vivo. Stem Cell Res Ther. 2017; 8 (1): 251. https://doi.org/10.1186/s13287-017-0706-z</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Eggers J.C., Martino V, Reinbold R., Schafer S.D., Kiesel L., Starzinski-Powitz A., Schuring A.N., Kemper B., Greve B., Gotte M. microRNA miR-200b affects proliferation, invasiveness and stemness of endometriotic cells by targeting ZEB1, ZEB2 and KLF4. Reprod Biomed Online. 2016; 32 (4): 434-45. https://doi.org/10.1016/j.rbmo.2015.12.013</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Dai L., Gu L.Y., Zhu J., Shi J., Wang Y., Ji F., Di W. Regulation of microRNA-199a on adhesion, migration and invasion ability of human endometrial stromal cells. Zhonghua Fu Chan Ke Za Zhi. 2011; 46 (11): 817-21.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Wang X.Q., Zhou W.J., Luo X.Z., et al. Synergistic effect of regulatory T cells and proinflammatory cytokines in angiogenesis in the endometriotic milieu. Hum Reprod. 2017; 32 (6): 1304-17. https://doi.org/10.1093/humrep/dex067</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Hawkins S.M., Creighton C.J., Han D.Y., Zariff A., Anderson M.L., Gunaratne P.H., Matzuk M.M. Functional microRNA involved in endometriosis. Mol Endocrinol. 2011; 25 (5): 821-32. https://doi.org/10.1210/me.2010-0371</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Nothnick W.B., Graham A., Holbert J., Weiss M.J. miR-451 deficiency is associated with altered endometrial fibrinogen alpha chain expression and reduced endometriotic implant establishment in an experimental mouse model. PLoS One. 2014; 9 (6): e100336. https://doi.org/10.1371/journal.pone.0100336</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Cheng F., Lu L., Wang H., Cheng H., Zhang D. Expression and Significance of miR-126 and miR-145 in Infertility due to Endometriosis. J. Coll Physicians Surg Pak. 2019; 29 (6): 585-7. https://doi.org/10.29271/jcpsp.2019.06.585</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Li X., Zhang W., Fu J., Xu Y., Gu R., Qu R., Li L., Sun Y., Sun X. MicroRNA-451 is down-regulated in the follicular fluid of women with endometriosis and influences mouse and human embryonic potential. Reprod Biol Endocrinol. 2019; 17 (1): 96. https://doi.org/10.1186/s12958-019-0538-z</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Yang P., Wu Z., Ma C., Pan N., Wang Y., Yan L. Endometrial miR-543 Is Downregulated During the Implantation Window in Women With Endometriosis-Related Infertility. Reprod Sci. 2019; 26 (7): 900-8. https://doi.org/10.1177/1933719118799199</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Petracco R., Dias A.C.O., Taylor H., Petracco A., Badalotti M., Michelon J.D.R., Marinowic D.R., Hentschke M., Azevedo P.N., Zanirati G., Machado D.C. Evaluation of miR-135a/b expression in endometriosis lesions. Biomed Rep. 2019; 11 (4): 181-7. https://doi.org/10.3892/br.2019.1237</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Petracco R., Grechukhina O., Popkhadze 5., Massasa E., Zhou Y., Taylor H.S. MicroRNA 135 regulates HOXA10 expression in endometriosis. J. Clin Endocrinol Metab. 2011; 96 (12): 1925-33. https://doi.org/10.1210/jc.2011-1231</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Pei T, Liu C., Liu T, Xiao L., Luo B., Tan J., Li X., Zhou G., Duan C., Huang W. miR-194-3p Represses the Progesterone Receptor and Decidualization in Eutopic Endometrium From Women With Endometriosis. Endocrinology. 2018; 159 (7): 2554-62. https://doi.org/10.1210/en.2018-00374</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Sultana S., Kajihara T., Mizuno Y., Sato T., Oguro T., Kimura M., Akita M., Ishihara O. Overexpression of microRNA-542-3p attenuates the differentiating capacity of endometriotic stromal cells. Reprod Med Biol. 2017; 16 (2): 170-8. https://doi.org/10.1002/rmb2.12028</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Maged A.M., Deeb W.S., El Amir A., Zaki S.S., El Sawah H., Al Mohamady M., Metwally A.A., Katta M.A. Diagnostic accuracy of serum miR-122 and miR-199a in women with endometriosis. Int J. Gynaecol Obstet. 2018; 141 (1): 14-9. https://doi.org/10.1002/ijgo.12392</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Kawabata A., Yanaihara N., Nagata C., Saito M., Noguchi D., Takenaka M., Iida Y., Takano H., Yamada K., Iwamoto M., Kiyokawa T, Okamoto A. Prognostic impact of interleukin-6 expression in stage I ovarian clear cell carcinoma. Gynecol Oncol. 2017; 146 (3): 609-14. https://doi.org/10.1016/j.ygyno.2017.06.027</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Nematian S.E., Mamillapalli R., Kadakia T.S., Majidi Zolbin M., Moustafa S., Taylor H.S. Systemic Inflammation Induced by microRNAs: Endometriosis-Derived Alterations in Circulating microRNA 125b-5p and Let-7b-5p Regulate Macrophage Cytokine Production. J. Clin Endocrinol Metab. 2018; 103 (1): 64-74. https://doi.org/10.1210/jc.2017-01199</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Tian X., Xu L., Wang P. MiR-191 inhibits TNF-a induced apoptosis of ovarian endometriosis and endometrioid carcinoma cells by targeting DAPK1. Int J. Clin Exp Pathol. 2015; 8 (5): 4933-42</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Dong M., Yang P., Hua F. MiR-191 modulates malignant transformation of endometriosis through regulating TIMP3. Med Sci Monit. 2015; 21: 915-20. https://doi.org/10.12659/ MSM.893872</mixed-citation></ref></ref-list></back></article>
